SNPS vs. IDXX
SNPS (Synopsys, Inc.) and IDXX (IDEXX Laboratories, Inc.) are both stocks. SNPS operates in Software - Infrastructure (Technology), while IDXX operates in Diagnostics & Research (Healthcare). Over the past 10 years, SNPS returned 24.15%/yr vs 20.14%/yr for IDXX. At a 0.35 correlation, their price movements are largely independent.
Performance
SNPS vs. IDXX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SNPS achieves a -3.37% return, which is significantly higher than IDXX's -17.09% return. Over the past 10 years, SNPS has outperformed IDXX with an annualized return of 24.15%, while IDXX has yielded a comparatively lower 20.14% annualized return.
SNPS
- 1D
- -0.53%
- 1M
- -10.88%
- YTD
- -3.37%
- 6M
- 0.21%
- 1Y
- -8.30%
- 3Y*
- 0.29%
- 5Y*
- 11.53%
- 10Y*
- 24.15%
IDXX
- 1D
- 0.53%
- 1M
- 6.09%
- YTD
- -17.09%
- 6M
- -20.35%
- 1Y
- 6.45%
- 3Y*
- 6.18%
- 5Y*
- -0.82%
- 10Y*
- 20.14%
SNPS vs. IDXX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SNPS Synopsys, Inc. | -3.37% | -3.22% | -5.74% | 61.27% | -13.35% | 42.15% | 86.24% | 65.24% | -1.17% | 44.82% |
IDXX IDEXX Laboratories, Inc. | -17.09% | 63.63% | -25.51% | 36.06% | -38.04% | 31.73% | 91.43% | 40.38% | 18.95% | 33.35% |
Correlation
The correlation between SNPS and IDXX is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.31 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.38 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.50 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.54 |
Correlation (All Time) Calculated using the full available price history since Feb 26, 1992 | 0.35 |
The correlation between SNPS and IDXX shifts across timeframes, from 0.31 (1 year) to 0.54 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
SNPS:
$4.57
IDXX:
$18.08
SNPS:
99.35
IDXX:
31.03
SNPS:
4.26
IDXX:
2.68
SNPS:
8.85
IDXX:
7.64
SNPS:
$8.68B
IDXX:
$4.45B
SNPS:
$6.38B
IDXX:
$2.76B
SNPS:
$2.22B
IDXX:
$1.52B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SNPS vs. IDXX — Risk / Return Rank
SNPS
IDXX
SNPS vs. IDXX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Synopsys, Inc. (SNPS) and IDEXX Laboratories, Inc. (IDXX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SNPS | IDXX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.30 | ||
| Sortino ratioReturn per unit of downside risk | -0.47 | ||
| Omega ratioGain probability vs. loss probability | 1.04 | 1.08 | -0.05 |
| Calmar ratioReturn relative to maximum drawdown | -0.20 | 0.21 | -0.41 |
| Martin ratioReturn relative to average drawdown | -0.32 | 0.42 | -0.74 |
Loading charts...
Drawdowns
SNPS vs. IDXX - Drawdown Comparison
The maximum SNPS drawdown since its inception was -60.95%, smaller than the maximum IDXX drawdown of -81.42%. Use the drawdown chart below to compare losses from any high point for SNPS and IDXX.
Loading charts...
Drawdown Indicators
| SNPS | IDXX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -60.95% | -81.42% | +20.47% |
Max Drawdown (1Y)Largest decline over 1 year | -41.04% | -31.04% | -10.00% |
Max Drawdown (3Y)Largest decline over 3 years | -41.04% | -37.41% | -3.63% |
Max Drawdown (5Y)Largest decline over 5 years | -41.04% | -54.00% | +12.96% |
Max Drawdown (10Y)Largest decline over 10 years | -41.04% | -54.00% | +12.96% |
Current DrawdownCurrent decline from peak | -29.67% | -26.84% | -2.83% |
Average DrawdownAverage peak-to-trough decline | -20.29% | -21.00% | +0.71% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 26.17% | 15.39% | +10.78% |
Volatility
SNPS vs. IDXX - Volatility Comparison
Synopsys, Inc. (SNPS) has a higher volatility of 13.66% compared to IDEXX Laboratories, Inc. (IDXX) at 8.02%. This indicates that SNPS's price experiences larger fluctuations and is considered to be riskier than IDXX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SNPS | IDXX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.66% | 8.02% | +5.64% |
Volatility (6M)Calculated over the trailing 6-month period | 30.93% | 20.47% | +10.46% |
Volatility (1Y)Calculated over the trailing 1-year period | 56.65% | 41.63% | +15.02% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 40.80% | 35.31% | +5.49% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 35.08% | 33.03% | +2.05% |
Dividends
SNPS vs. IDXX - Dividend Comparison
Neither SNPS nor IDXX has paid dividends to shareholders.
Financials
SNPS vs. IDXX - Financials Comparison
This section allows you to compare key financial metrics between Synopsys, Inc. and IDEXX Laboratories, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SNPS vs. IDXX - Profitability Comparison
SNPS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Synopsys, Inc. reported a gross profit of 1.65B and revenue of 2.28B. Therefore, the gross margin over that period was 72.3%.
IDXX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, IDEXX Laboratories, Inc. reported a gross profit of 722.74M and revenue of 1.14B. Therefore, the gross margin over that period was 63.4%.
SNPS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Synopsys, Inc. reported an operating income of 120.43M and revenue of 2.28B, resulting in an operating margin of 5.3%.
IDXX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, IDEXX Laboratories, Inc. reported an operating income of 362.59M and revenue of 1.14B, resulting in an operating margin of 31.8%.
SNPS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Synopsys, Inc. reported a net income of 16.87M and revenue of 2.28B, resulting in a net margin of 0.7%.
IDXX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, IDEXX Laboratories, Inc. reported a net income of 278.45M and revenue of 1.14B, resulting in a net margin of 24.4%.
Frequently Asked Questions
SNPS and IDXX have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SNPS has higher volatility (13.66%) compared to IDXX (8.02%). In terms of maximum drawdown, SNPS dropped -60.95% vs IDXX's -81.42%.
IDXX currently has the higher Sharpe Ratio (0.16 vs -0.15), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SNPS and IDXX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer